This inventor holds 1 USPTO granted patent. Top assignee: Ucb Pharma, S.a.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: The Innovative Mind of Frank Driessens: A Profile
Introduction: Frank Driessens is a prominent inventor based in Brussels, Belgium. With a strong focus on chemical processes, he has made significant strides in the field of pharmacology through his inventive contributions. His expertise and creativity are exemplified in his patent, showcasing his capabilities and dedication to innovation in the pharmaceutical industry.
Latest Patents: Frank Driessens holds a patent for a novel "Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation." This invention introduces a new method for creating 2-oxo-1-pyrrolidine derivatives of general formula (I). The process involves the cyclisation of an intermediate of general formula (II), wherein the substituents are defined within the specification. This advancement highlights his focus on enhancing chemical synthesis processes, which are crucial in developing new drugs and therapeutic solutions.
Career Highlights: Currently, Frank Driessens is employed by UCB Pharma, S.A., a leading global biopharmaceutical company. At UCB Pharma, he has the opportunity to work at the forefront of medicinal innovation. His contributions to the company and the pharmaceutical field are marked by his patent, which demonstrates his commitment to improving health outcomes through innovative processes.
Collaborations: Throughout his career, Frank has collaborated with esteemed colleagues, including Françoise Lurquin and Michel Callaert. These partnerships not only enhance his work but also foster a collaborative environment that is vital for research and development in the fast-paced pharmaceutical industry. Together, they represent a team dedicated to pushing the boundaries of medical research and development.
Conclusion: Frank Driessens stands out as an inventive force in the realm of pharmaceutical innovation. His patented process for synthesizing 2-oxo-1-pyrrolidine derivatives serves as a testament to his ingenuity and dedication to advancing medical science. As a key player at UCB Pharma, he continues to pave the way for new developments that hold the potential to improve countless lives. Through collaboration and creativity, Frank Driessens exemplifies the essence of innovation in the pharmaceutical sector.